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Transapical aortic valve implantation in humans
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See related editorial on page 941.
Calciﬁc aortic stenosis is the most common valvular diseaseaffecting the elderly. Surgical aortic valve replacementimproves symptoms and prognosis, but mortalities maybe as high as 20% in elderly patients with left ventricular
dysfunction.1 Catheter-based aortic valve implantation was recently
achieved through antegrade venous2 and retrograde arterial routes.3
We report on the deployment of an aortic valve prosthesis for severe
aortic stenosis through the apex of the left ventricle in a 75-year-old
patient without cardiopulmonary bypass or sternotomy.
Methods
Case Report
The procedure was approved by the Therapeutic Products Di-
rectorate, Department of Health and Welfare, Ottawa, Canada,
for compassionate clinical use in patients deemed not to be
candidates for surgery and without arterial access.
An emaciated, 52-kg, 75-year-old woman presented in conges-
tive heart failure. Comorbidities included restrictive lung disease,
severe psoriatic arthropathy, a calciﬁed thoracic aorta, a large
infrarenal aortic aneurysm, and bilateral aortoiliac disease. Cardiac
catheterization revealed pulmonary hypertension and severe aortic
stenosis with a mean gradient of 54 mm Hg and 0.4 cm2 valve
area. Echocardiograms demonstrated a mean gradient of 31 to 48
mm Hg, 0.7 to 0.8 cm2 valve area, 23-mm ventriculo-annular
diameter, and ejection fraction of 35% (Figure 1, A).
The patient was evaluated by 2 surgeons who believed the
operative risk was unacceptable, and she was referred for consid-
eration of transapical deployment of an aortic valve prosthesis.
Procedure and Results
The procedure took place in the operating room under general
anesthesia on October 27, 2005. A portable C-arm provided
ﬂuoroscopy. Aortography, through a right femoral arterial
sheath, and transesophageal echocardiography were used to
facilitate positioning of the prosthesis. The patient was premed-
icated with 300 mg clopidogrel, 81 mg aspirin, and vancomycin
1 g intravenously.
The pleural space was entered through a 5-to-8-cm sixth inter-
costal anterolateral thoracotomy. The pericardium over the apex of
the left ventricle was identiﬁed and opened. To permit a 24F
sheath, 2 paired orthogonal U-shaped sutures with pledgets were
placed into the myocardium and passed through tensioning tour-
niquets. Temporary epicardial pacing wires were placed. Test
pacing was performed to ensure reliable 1:1 capture at 150 to 200
beats/min and reduction in arterial pressure to less than 50 mm Hg.
During valvuloplasty and prosthesis deployment, rapid pacing was
used to minimize transaortic ﬂow.
After 5000 units of heparin were administered, an 8F Angio-
cath was inserted through the apex of the left ventricle and a
guidewire was passed through the aortic valve and down the
descending aorta for stability. The Angiocath was exchanged for a
14F catheter, and a 20-mm balloon valvuloplasty was performed in
preparation for valve deployment.
The Cribier valve (Edwards Lifesciences Inc, Irvine, Calif)
is a 26-mm stainless-steel stent with an attached equine peri-
cardial trileaﬂet valve and an annular fabric cuff. The valve was
supplied sterile in glutaraldehyde and required onsite mechan-
ical crimping onto a valvuloplasty balloon. A stiff 24F valve
delivery sheath was introduced into the left ventricle and con-
sciously kept in line with the aortic valve. The collapsed pros-
thetic valve was positioned by aortic root angiography (Figure 2, A)
and echocardiography.
A coordinated approach was developed. One individual ob-
served the ﬂuoroscopic image and maintained ideal valve position.
A second individual initiated pacing. A third individual conﬁrmed
pacemaker capture and reduction in arterial pressure before rapidly
inﬂating and deﬂating the stent deployment balloon.
Echocardiography reported a resultant valve area of 1.9 cm2
with a 3 mm Hg gradient (Figure 1, B). Aortic root angiography con-
ﬁrmed appropriate placement with no regurgitation (Figure 2, B).
Hemostasis was secured with previously placed pledgeted su-
tures. The pericardium was reapproximated to allow drainage and
prevent myocardial herniation. A left chest tube drained 200 mL of
serosanguineous ﬂuid.
The patient was well and able to walk 3 days postprocedure
without neurologic defects or shortness of breath. Repeat echocar-
diogram demonstrated a well-seated, normally functioning pros-
thesis without regurgitation. She was placed on 75 mg clopidogrel
for 2 months and 81 mg aspirin daily. Because she lives alone, she
was discharged 9 days postprocedure.
The 1-month postoperative echocardiogram demonstrated a
valve area of 1.7 cm2 with minimal paravalvular insufﬁciency. At
approximately 2 months follow-up she remains in sinus rhythm,
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free of complications, and without any heart failure, functionally
limited only by preexisting arthropathy.
Discussion
This case demonstrates the successful implantation of an aortic
valve prosthesis for aortic stenosis through the apex of the left
ventricle without sternotomy or the use of cardiopulmonary bypass
in a human. The resultant hemodynamics and valve area are
compatible with those achievable with open surgical replacement.
At present this procedure is offered to symptomatic patients
deemed to be nonsurgical candidates without peripheral arterial
access. With technologic advances, improved techniques, better
understood selection criteria, and prosthesis durability, the in-
dications may be expanded to high-risk surgical candidates.
This case demonstrates the feasibility of this approach and
portends an evolving future for transchamber treatment of intra-
cardiac pathology by cardiac surgeons.
We thank Dr Todd Dewey for his advice and guidance in this case.
Figure 1. Transesophageal echocardiogram. Transesophageal
echocardiogram (preoperative and postoperative long access). A,
Long access—preoperative. Maximum opening of the thickened
leaﬂets is severely restricted. Restrictive calcium can be visualized
at the annulus and on the leaﬂets. B, Long access—postoperative.
Stent valve is well positioned with unrestricted leaﬂet opening.
Figure 2. Ascending aortograms. Ascending aortograms (posi-
tioning of valve prosthesis before implantation and after pros-
thetic valve implantation). A, Positioning of valve prosthesis
before implantation. A, Transesophageal echocardiogram probe
to help with positioning at the aortic annulus and apical left
ventricular deployment catheter and sheath. B , After prosthetic
valve implantation. B, Prosthesis is positioned at the annulus and
below the coronary ostia. There is no aortic insufﬁciency.
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Nourishing vascularization of a thymoma issued from a left internal
thoracic artery graft
Pascal A. Thomas, MD, Frédéric Collart, MD, Christophe Doddoli, MD, Vlad Gariboldi, MD,
and Guy Moulin, MD, Marseille, France
A71-year-old man underwent chest computed tomo-graphic (CT) scan in June 2002 as part of an ongoingprogram for thoracic malignancy screening becausehe was a former worker with signiﬁcant exposure to
asbestos. In 1988, he had received one left internal thoracic artery
(LITA) graft to the mid left anterior descending artery and one
saphenous vein graft to the ﬁrst marginal branch of the left cir-
cumﬂex artery because of severe angina. The chest CT scan
identiﬁed a 5-cm homogeneous anterior mediastinal mass located
on the left aspect of the thymic area (Figure 1). The LITA graft
was shown as contiguous with the tumor. Selective catheterization
of the LITA disclosed a patent graft as well as a rich, nourishing
vasculature supplying the tumor and originating from the graft
(Figure 2). Coronary arteriography revealed severe native vessel
disease with complete occlusion of the right and 70% obstruction of
the distal left main coronary arteries. Left ventriculography showed
no wall motion abnormalities and an ejection fraction of 60%. The
patient underwent percutaneous transluminal left main coronary an-
gioplasty with stent placement on July 2002, followed by a 60-day
course of clopidogrel with aspirin, subsequently relieved with daily
subcutaneous injections of enoxaparin. In October 2002, the patient
was operated on through a left lateral thoracotomy. The tumor was
adherent to the pericardium and the LITA graft. It was carefully
freed from the graft with elective control of all collateral microves-
sels by bipolar electrocoagulation forceps, division of the thymic
veins draining into the innominate vein, and establishment of the
lateral margin of resection just anterior to the left phrenic nerve.
The patient made an uneventful recovery and was discharged on
day 11.
Pathologic examination revealed a mixed thymoma according
to the Müller-Hermelink classiﬁcation, with focal invasion of the
capsule. The patient was given adjuvant radiotherapy to the me-
diastinum (50 Gy in 25 fractions). He remains free from recurrence
and angina 3 years after the operation.
Discussion
Surgery remains the standard of care for encapsulated thymomas,
with high cure rates anticipated. Thymomas are the most common
thymic tumor in adults, usually with an indolent growth pattern.
Understandably, the fortuitous discovery of a thymoma during a
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Figure 1. CT scan of the chest showing an anterior mediastinal
mass and the LITA graft as an adjacent contrast-enhanced vessel
along its anterior aspect.
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